PHOTOPHARMICA
Photopharmica is discovers and develops photo sensitizers and light sources for medical use in the United Kingdom. It develops anti-infective agents primarily for dermatology and wound management markets; and medical devices in the fields of orthopedics and periodontal equipment. Its products pipeline includes phenothiazinium photo sensitizers for use as topical therapeutic antimicrobial agents; phenothiazinium photo sensitizers for systemic oncology use; and phthalocyanine photo sensitizers that combine anti-tumor properties with minimal or zero skin photo sensitization.
PHOTOPHARMICA
Industry:
Medical Medical Device Pharmaceutical
Founded:
2001-01-01
Address:
Leeds, Leeds, United Kingdom
Country:
United Kingdom
Status:
Active
Contact:
+44 11 3384 6092
Similar Organizations
Digital Pharma Lab
Digital Pharma Lab is a discharge to assess digital acceleration program that focuses on manufacturing in the healthcare industry.
Haemato
Haemato is a pharmaceutical company that develops customized medical devices for healthcare sectors.
More informations about "Photopharmica"
Photopharmica - Crunchbase Company Profile & Funding
Photopharmica is discovers and develops photo sensitizers and light sources for medical use in the United Kingdom. It develops anti-infective agents primarily for dermatology and wound management markets; and medical devices in the fields of orthopedics and periodontal …See details»
Professors of Practice bring heart of busines to the …
Feb 11, 2013 Lyon left Covance to help set up Photopharmica, developing drugs to fight cancer and infections. Having worked for venture capital firm and now a business angel, Lyon has helped a myriad of small and medium-sized …See details»
Photopharmica - Products, Competitors, Financials, Employees ...
Photopharmica, developing light sensitive drugs for the prevention and treatment of diseases in the anti-infective and oncology markets photosensitisers, for industrial applications. Use the …See details»
REF Case study search
Photopharmica has raised £11.5M in external investment, around £6.0M of which has been deployed since 2009 to support a 57 patient phase IIb clinical trial. The results, which showed …See details»
Photopharmica - VentureRadar
Photopharmica was formed to develop light sensitive drugs for indications including oncology and infection. The company's technology uses small molecules that are activated by light, called …See details»
Photodynamic Therapy for Infections: Clinical …
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ... was carried out by a UK based company, Photopharmica. Improved would healing and microbial …See details»
Photopharmica - Company Profile - Tracxn
Mar 4, 2025 Photopharmica - Developer of light-sensitive drugs for oncology and infection. Photopharmica has 2906 competitors.See details»
Photopharmica Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Photopharmica Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, and 1 literature, Drug:PPA-904, PPA-905.See details»
Photopharmica Ltd.:Company Profile & Technical …
Photopharmica Ltd. is headquartered in United Kingdom LEEDS. Photopharmica Ltd. was founded in 2001. Photopharmica Ltd. has a total of 114 patents . Related Topics. Medical …See details»
Organization | Photopharmica
Photopharmica Report issue. For profit Phase 2. Founded: Leeds United Kingdom ... Organization Overview. First Clinical Trial. 2009 NCT00825760. First Marketed Drug. None First NDA …See details»
PPA-905 - Drug Targets, Indications, Patents - Synapse
PPA-905, Initially developed by Photopharmica Ltd., Now, its global highest R&D status is Pending, Therapeutic Areas: Skin and Musculoskeletal Diseases,Other Diseases. Products. …See details»
Research programme: photodynamic therapy - Photopharmica
Photopharmica is developing light sensitive drugs (known as photosensitisers) for the treatment of cancer and infection. Several phenothiazinium Research programme: photodynamic therapy - …See details»
Photopharmica Ltd. (Photopharmica Ltd.) - 药物管线_专利_临床试 …
了解Photopharmica Ltd. (Photopharmica Ltd.)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验和1篇文献，药物:PPA-904，PPA-905。See details»
Stephen John Lyon - Photopharmica Limited, Leeds
Stephen John Lyon was associated with Photopharmica Limited between 2013 and 2019. They may have been associated with this organization before or after these years as well. …See details»
PhotoPharmics - Crunchbase Company Profile & Funding
PhotoPharmics is a clinical-stage medical device company developing next-generation treatments for treating neurodegenerative disorders.See details»
Photopharmica Research Ltd - 1stdirectory.co.uk
Photopharmica Research Ltd Leeds, × First Directory is a free resource to bring you more business. We have: 60,000 contract/tender opportunities per yearSee details»
Specialized Phototherapy - PhotoPharmics
Feb 28, 2025 ADDRESSING MAJOR UNMET NEEDS A Breakthrough Therapy for People Living with Parkinson’s Disease. Specialized phototherapy addresses both motor and non …See details»
Working at Photopharmica - Glassdoor
Photopharmica. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. Claim your …See details»
NatMed Pro - PhytoPharmica - therapeuticresearch.com
NatMed Pro - THE Authority on Natural Medicines. Ⓒ 2025 Therapeutic Research Center. Commercial distribution or reproduction prohibitedSee details»
PHYTOPHARMICA THE LEADER IN NATURAL MEDICINES
TrademarkElite is the U.S. #1 Trademark Search and Registration Service :: PHYTOPHARMICA THE LEADER IN NATURAL MEDICINES is a trademark and brand of Enzymatic Therapy, …See details»